In recent years, DNMT inhibitors have been developed for cancer treatment.[5] Our findings underscore the necessity for developing DNMT agonists or therapeutic strategies aimed at increasing DNA methylation to treat neurological disorders. Here, DNMT1 is linked to nervous system disorder.